39.00
前日終値:
$39.50
開ける:
$38.85
24時間の取引高:
1.17M
Relative Volume:
0.76
時価総額:
$8.86B
収益:
$5.30B
当期純損益:
$-624.00M
株価収益率:
-12.71
EPS:
-3.0692
ネットキャッシュフロー:
$42.00M
1週間 パフォーマンス:
-4.36%
1か月 パフォーマンス:
-0.84%
6か月 パフォーマンス:
-6.50%
1年 パフォーマンス:
-36.34%
Lineage Inc Stock (LINE) Company Profile
Compare LINE vs PLD, PSA, EXR, EGP, CUBE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
LINE
Lineage Inc
|
39.00 | 8.97B | 5.30B | -624.00M | 42.00M | -3.0692 |
|
PLD
Prologis Inc
|
135.15 | 125.06B | 8.79B | 3.57B | 4.12B | 3.5567 |
|
PSA
Public Storage
|
306.48 | 54.08B | 4.82B | 1.80B | 2.90B | 9.0144 |
|
EXR
Extra Space Storage Inc
|
146.29 | 30.96B | 3.38B | 1.02B | 1.69B | 4.5319 |
|
EGP
Eastgroup Properties Inc
|
190.15 | 10.03B | 721.34M | 257.46M | 404.90M | 4.8717 |
|
CUBE
Cubesmart
|
40.08 | 9.17B | 1.08B | 385.85M | 627.25M | 1.68 |
Lineage Inc Stock (LINE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-13 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2025-12-18 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | ダウングレード | BofA Securities | Buy → Underperform |
| 2025-07-01 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-06-23 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2025-06-23 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-06-12 | ダウングレード | BNP Paribas Exane | Neutral → Underperform |
| 2025-05-06 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-04-10 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-28 | 開始されました | Citigroup | Neutral |
| 2025-01-14 | 開始されました | Exane BNP Paribas | Neutral |
| 2024-12-20 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-09-18 | 開始されました | CapitalOne | Overweight |
| 2024-09-16 | 開始されました | CapitalOne | Overweight |
| 2024-08-19 | 開始されました | Deutsche Bank | Hold |
| 2024-08-19 | 開始されました | Evercore ISI | In-line |
| 2024-08-19 | 開始されました | Goldman | Buy |
| 2024-08-19 | 開始されました | JP Morgan | Overweight |
| 2024-08-19 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2024-08-19 | 開始されました | Mizuho | Neutral |
| 2024-08-19 | 開始されました | Morgan Stanley | Overweight |
| 2024-08-19 | 開始されました | Piper Sandler | Overweight |
| 2024-08-19 | 開始されました | Robert W. Baird | Outperform |
| 2024-08-19 | 開始されました | Scotiabank | Sector Outperform |
| 2024-08-19 | 開始されました | Truist | Buy |
| 2024-08-19 | 開始されました | UBS | Neutral |
| 2024-08-19 | 開始されました | Wells Fargo | Equal Weight |
すべてを表示
Lineage Inc (LINE) 最新ニュース
Lineage (LINE) Price Target Increased to $44 by RBC Capital on Q4 FFO Strength - Finviz
US Market Wrap: Is Klotho Neurosciences Inc gaining market shareGap Down & Daily Technical Forecast Reports - baoquankhu1.vn
Lineage Inc (LINE) Stock Price Down 3.87% on Mar 9 - GuruFocus
H.C. Wainwright Maintains Buy on Lineage Cell Therapeutics (LCTX) Mar 2026 - Meyka
2026-03-08 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lineage, Inc. (LINE) And Encourages Stockholders to Reach Out | NDAQ:LINE | Press Release - Stockhouse
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2025 Earnings Call Transcript - Insider Monkey
Why Lineage Cell Therapeutics Inc. stock could outperform in 2026Portfolio Performance Summary & Free Verified High Yield Trade Plans - Naître et grandir
Can Lineage Cell Therapeutics Inc. stock resist market sell offsQuarterly Growth Report & Long Hold Capital Preservation Plans - Naître et grandir
Lineage, Inc. Earnings Call Balances Progress And Pressure - TipRanks
Lineage Inc (LINE) Trading Down 3.24% on Mar 6 - GuruFocus
Lineage Cell Therapeutics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides B - PharmiWeb.com
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Business Wire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Stockholders to Connect - ACCESS Newswire
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 - Investing News Network
LINE PE Ratio & Valuation, Is LINE Overvalued - Intellectia AI
LCTX SEC FilingsLineage Cell The 10-K, 10-Q, 8-K Forms - Stock Titan
A Look Ahead: Lineage Cell Therapeutics's Earnings Forecast - Benzinga
Lineage (LINE) Is Up 5.1% After Returning to Quarterly Profitability on Flat SalesWhat's Changed - simplywall.st
Analysts Offer Insights on Real Estate Companies: Equity Residential (EQR) and Lineage, Inc. (LINE) - The Globe and Mail
LINE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LINE (NASDAQ: LINE) Form 144 notice: proposed sale of 7,983 shares - Stock Titan
Lineage Point Capital discloses 1.1M shares in TGE Value (BEBE) - Stock Titan
Assessing Lineage (NasdaqGS:LINE) Valuation After Q4 Profit Swing And Narrowed Annual Net Loss - simplywall.st
Wells Fargo & Company Forecasts Strong Price Appreciation for Lineage (NASDAQ:LINE) Stock - MarketBeat
Lineage (LINE) Price Target Raised by Wells Fargo to USD 39 | LI - GuruFocus
RBC Raises Price Target on Lineage to $44 From $42, Keeps Outperform Rating - marketscreener.com
Waterfall Asset Management LLC Invests $6.28 Million in Lineage, Inc. $LINE - MarketBeat
Lineage: Cold Storage REIT Still Undervalued Thanks To Near-Term Headwinds (NASDAQ:LINE) - Seeking Alpha
Lineage Cell Therapeutics IncWithdrew CIRM Grant Application Filed In June 2025SEC Filing - TradingView
Artisan Partners Limited Partnership Trims Stock Position in Lineage, Inc. $LINE - MarketBeat
Panic Selling: Is Lineage Inc benefiting from innovation trendsMarket Activity Report & Reliable Trade Execution Plans - baoquankhu1.vn
Is It Time To Reassess Lineage (LINE) After Recent Real Estate Sector Rethink? - simplywall.st
LINE Investors Have Opportunity to Join Lineage, Inc. Fraud Investigation With the DJS Law Group - 富途牛牛
Lineage (NASDAQ:LINE) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
LCTX PE Ratio & Valuation, Is LCTX Overvalued - Intellectia AI
Lineage (LINE) Stock Target Price Raised by Piper Sandler | LINE - GuruFocus
Analysts Offer Insights on Real Estate Companies: Lineage, Inc. (LINE) and Pebblebrook Hotel (PEB) - The Globe and Mail
Greg Lehmkuhl: Strategic Logistics Leader, Lineage President and CEO, and Pioneer in Global Cold Chain Transformation - BBN Times
What 7 Analyst Ratings Have To Say About Lineage - Benzinga
Maintaining a Buy on Lineage, Inc.: Operational Discipline and Cost Efficiencies Support 2026 Outlook Amid Macro Headwinds - TipRanks
Centersquare Investment Management LLC Trims Stock Holdings in Lineage, Inc. $LINE - MarketBeat
Balanced Risk-Reward Keeps Lineage Inc. at Hold Amid Weaker Fundamentals and Soft 2026 Guidance - TipRanks
Lineage (LINE) Reports AFFO Of US$214 million - simplywall.st
Lineage Q4 2025 slides: occupancy improves amid capacity glut By Investing.com - Investing.com Australia
Lineage (LINE) CEO gets 13,756-share award, 3,995 withheld for taxes - Stock Titan
[Form 4] Lineage, Inc. Insider Trading Activity - Stock Titan
Lineage (LINE) CCO gets 3,603-share award, 1,169 shares withheld for taxes - Stock Titan
Lineage (LINE) officer gets stock grant as RSUs vest, shares withheld for taxes - Stock Titan
Lineage, Inc. (LINE) HR chief reports RSU vesting and tax share withholding - Stock Titan
Why Lineage, Inc. Stock Is Climbing Today - TipRanks
Lineage Inc (LINE) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):